Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olaparib in Metastatic Urothelial Cancer with DDR Alterations
NCT03448718Phase 2Completed
- Start
- Apr 2018
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of olaparib in urothelial carcinoma (UC). Started Apr 2018; status: completed.
02
Drugs
olaparib
03
Conditions
urothelial carcinoma (UC)
Beyond the preview
Go deeper on NCT03448718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03448718.